1. Home
  2. BIAF vs HTCR Comparison

BIAF vs HTCR Comparison

Compare BIAF & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • HTCR
  • Stock Information
  • Founded
  • BIAF 2014
  • HTCR 2009
  • Country
  • BIAF United States
  • HTCR Japan
  • Employees
  • BIAF N/A
  • HTCR N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HTCR EDP Services
  • Sector
  • BIAF Health Care
  • HTCR Technology
  • Exchange
  • BIAF Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • BIAF 12.2M
  • HTCR 12.8M
  • IPO Year
  • BIAF 2022
  • HTCR 2022
  • Fundamental
  • Price
  • BIAF $0.30
  • HTCR $0.52
  • Analyst Decision
  • BIAF Hold
  • HTCR
  • Analyst Count
  • BIAF 1
  • HTCR 0
  • Target Price
  • BIAF N/A
  • HTCR N/A
  • AVG Volume (30 Days)
  • BIAF 11.2M
  • HTCR 194.5K
  • Earning Date
  • BIAF 08-13-2025
  • HTCR 08-13-2025
  • Dividend Yield
  • BIAF N/A
  • HTCR 3.92%
  • EPS Growth
  • BIAF N/A
  • HTCR N/A
  • EPS
  • BIAF N/A
  • HTCR N/A
  • Revenue
  • BIAF $8,809,228.00
  • HTCR $28,947,523.00
  • Revenue This Year
  • BIAF N/A
  • HTCR N/A
  • Revenue Next Year
  • BIAF $20.00
  • HTCR $8.59
  • P/E Ratio
  • BIAF N/A
  • HTCR N/A
  • Revenue Growth
  • BIAF 78.40
  • HTCR 59.42
  • 52 Week Low
  • BIAF $0.16
  • HTCR $0.49
  • 52 Week High
  • BIAF $2.99
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 50.96
  • HTCR 44.82
  • Support Level
  • BIAF $0.22
  • HTCR $0.54
  • Resistance Level
  • BIAF $0.46
  • HTCR $0.55
  • Average True Range (ATR)
  • BIAF 0.04
  • HTCR 0.03
  • MACD
  • BIAF 0.01
  • HTCR 0.00
  • Stochastic Oscillator
  • BIAF 30.51
  • HTCR 44.83

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: